FY2025 · period end Dec '25 · from the 10-K filed Mar 17, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.03B |
| Gross Profit | — | — | — | $0.00B | negative: -$0.00B |
| Operating Income | negative: -$0.10B | negative: -$0.26B | negative: -$0.32B | negative: -$0.02B | negative: -$0.03B |
| Net Income | negative: -$0.13B | negative: -$0.25B | negative: -$0.27B | negative: -$0.02B | negative: -$0.03B |
| EPS (Diluted) | negative: -$2.78 | negative: -$10.83 | negative: -$25.95 | negative: -$18.36 | negative: -$0.78 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.31B | $0.35B | $0.54B | $0.02B | $0.04B |
| Total Liabilities | $0.28B | $0.25B | $0.21B | $0.02B | $0.02B |
| Stockholders' Equity | $0.02B | $0.09B | $0.29B | $0.01B | $0.01B |
| Cash & Equivalents | $0.01B | $0.01B | $0.03B | $0.00B | $0.01B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.05B | negative: -$0.06B | negative: -$0.05B | negative: -$0.02B | negative: -$0.02B |
| Capital Expenditures | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | negative: -$0.05B | negative: -$0.06B | negative: -$0.05B | negative: -$0.02B | negative: -$0.02B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | 100.0% | negative: -9.9% |
| Operating Margin | negative: -2680.1% | negative: -6062.8% | negative: -17550.0% | negative: -14248.4% | negative: -1.1% |
| Net Margin | negative: -3492.3% | negative: -5898.4% | negative: -14729.1% | negative: -10758.6% | negative: -1.1% |
| Return on Equity | negative: -223.0% | negative: -130.4% | negative: -178.0% | negative: -158.1% | negative: -114.5% |
| Return on Assets | negative: -38.8% | negative: -56.2% | negative: -94.4% | negative: -56.7% | negative: -58.1% |
| Debt / Equity | 0.02× | 0.01× | 0.00× | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001628280-26-056731 | Aug 13, 2026 | Aug 13, 2026 | Aug 13, 2026 20:14 UTC | EDGAR |
| 10-Q | 0001628280-26-056773 | Jun 30, 2026 | Aug 13, 2026 | Aug 13, 2026 20:32 UTC | EDGAR |
| 8-K | 0001628280-26-041775 | Jun 8, 2026 | Jun 9, 2026 | Jun 9, 2026 12:19 UTC | EDGAR |
| 8-K | 0001628280-26-041069 | Jun 2, 2026 | Jun 5, 2026 | Jun 5, 2026 12:45 UTC | EDGAR |
| 8-K | 0001628280-26-035105 | May 14, 2026 | May 14, 2026 | May 14, 2026 20:11 UTC | EDGAR |
| 10-Q | 0001628280-26-035159 | Mar 31, 2026 | May 14, 2026 | May 14, 2026 20:40 UTC | EDGAR |
| 8-K | 0001628280-26-024746 | Apr 7, 2026 | Apr 10, 2026 | Apr 10, 2026 21:06 UTC | EDGAR |
| 8-K | 0001193125-26-127706 | Mar 25, 2026 | Mar 27, 2026 | Mar 27, 2026 12:45 UTC | EDGAR |
Direct links to SEC EDGAR. CBUS has additional filings available on the SEC site.
6 numbers Cibus, Inc. later changed — same XBRL tag, both filings linked.
Net Cash Provided by (Used in) Operating Activities·Q1 2020
Minor restatementwas-$12.4M
Revised up in a 10-Q.
Operating Income (Loss)·Q3 2020
Minor restatementwas-$9.2M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q1 2019
Minor restatementwas-$9.3M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Financing Activities·Q1 2019
Major restatementwas$125K
Revised down in a 10-Q.
Net Cash Provided by (Used in) Investing Activities·FY 2018
Notable restatementwas-$1.8M
Revised down in a 10-K.
Operating Expenses·Q3 2020
Minor restatementwas$7.3M
Revised down in a 10-Q.
CBUS is not the only one.
See every restatement we've found across the market — or get an alert the next time CBUS revises a number.
Restatements are detected by comparing every vintage of a fact across all of Cibus, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CBUS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Cibus, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CBUS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CBUS and publish the result to your public profile.
Ask about Cibus, Inc.
Continue in Workspace — cited answers on CBUS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs